Advanced Solid Malignancies Terminated Phase 1 Trials for Gemcitabine (DB00441)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00733031Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918Treatment
NCT00937664Safety and Tolerability Study of AZD7762 in Combination With GemcitabineTreatment